The meta-analysis of randomized controlled trials showed that NSAIDs, the first line medicine for the AGA, had no direct effect on the CRP level in rheumatoid arthritis and ankylosing spondylitis [36, 37] which both are inflammatory arthritis. The gene discussed is CRP; the disease is rheumatoid arthritis.